NeuroShield Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
Liquidation
NeuroShield General Information
Description
Developer of a chitosan-based membrane designed to help in peripheral nerve repair. The company's membrane shields nerves from further damage and promotes fast regrowth, enabling patients to have accelerated recovery from nerve damage.
Contact Information
Website
www.monarchbioimplants.com(Operating Subsidiary)
Corporate Office
- Platz 4, D4
- 6039 Root
- Switzerland
Corporate Office
- Platz 4, D4
- 6039 Root
- Switzerland
NeuroShield Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 07-Apr-2024 | Completed | Bankruptcy: Liquidation | |||
| 4. Merger/Acquisition | 12-Aug-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 28-Sep-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 20-Jul-2017 | $1.48M | $1.48M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
NeuroShield Patents
NeuroShield Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3972562-A1 | Medical device comprising a chitosan-based support structure | Active | 22-May-2019 | ||
| EP-3972562-B1 | Medical device comprising a chitosan-based support structure | Active | 22-May-2019 | ||
| US-12569590-B2 | Medical device comprising a chitosan-based support structure | Active | 22-May-2019 | ||
| US-20220218870-A1 | Medical device comprising a chitosan-based support structure | Active | 22-May-2019 | ||
| WO-2020234740-A1 | Medical device comprising a chitosan-based support structure | Inactive | 22-May-2019 | A61L27/26 |
NeuroShield Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fast Track Venture | Venture Capital | Minority | ||
| Global Emerging Markets | PE/Buyout | Minority | ||
| Technopark Luzern | Accelerator/Incubator |
NeuroShield FAQs
-
When was NeuroShield founded?
NeuroShield was founded in 2016.
-
Where is NeuroShield headquartered?
NeuroShield is headquartered in Root, Switzerland.
-
What industry is NeuroShield in?
NeuroShield’s primary industry is Therapeutic Devices.
-
Is NeuroShield a private or public company?
NeuroShield is a Private company.
-
What is NeuroShield’s current revenue?
The current revenue for NeuroShield is .
-
How much funding has NeuroShield raised over time?
NeuroShield has raised $25.1M.
-
Who are NeuroShield’s investors?
Fast Track Venture, Global Emerging Markets, and Technopark Luzern have invested in NeuroShield.
-
When was NeuroShield acquired?
NeuroShield was acquired on 07-Apr-2024.
-
Who acquired NeuroShield?
NeuroShield was acquired by Checkpoint Surgical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process